신경혈전제거 기기 시장 규모, 점유율, 동향, 산업 분석 보고서 : 제품별, 최종 용도별, 지역별 - 시장 예측(2025-2034년)

The neurothrombectomy devices market size is expected to reach USD 1,418.33 million by 2034, according to a new study by Polaris Market Research. The report "Neurothrombectomy Devices Market Size, Share, Trends, Industry Analysis Report: By Product (Clot Retrievers, Aspiration/Suction Devices, and Vascular Snares), End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The neurothrombectomy devices market focuses on medical instruments designed to remove blood clots from the brain in patients suffering from acute ischemic stroke, helping restore blood flow and prevent neurological complications. The market is experiencing significant growth due to the rising incidence of stroke globally, increasing adoption of minimally invasive procedures, and continuous technological advancements in clot retrieval and aspiration devices. Neurothrombectomy devices market opportunities are emerging in developing regions where improving healthcare infrastructure and awareness are driving demand for advanced stroke treatments. Key trends include the integration of artificial intelligence for stroke diagnosis, expanding clinical research for product innovation, and growing reimbursement support in developed markets. With increasing regulatory approvals and strategic collaborations among market players, the neurothrombectomy devices market is expected to expand further in the coming years.

Neurothrombectomy Devices Market Report Highlights

By product, the clot retrievers segment accounted for the largest share of the neurothrombectomy devices market revenue in 2024 due to their high efficacy in mechanical thrombectomy procedures, while aspiration/suction devices are expected to witness the highest growth due to advancements in vacuum-assisted clot removal technologies.

By end use, the hospitals segment dominated the neurothrombectomy devices market share as they are the primary centers for stroke treatment with well-equipped neurovascular units, while ambulatory surgical centers are experiencing rapid growth due to increasing demand for minimally invasive procedures and faster patient recovery.

North America holds the largest market share due to advanced healthcare infrastructure, high stroke incidence, and strong reimbursement policies, while Asia-Pacific is the fastest-growing region driven by rising healthcare investments, increasing awareness, and improving stroke management facilities.

A few major companies in the market are Abbott Laboratories; Acandis GmbH; AngioDynamics, Inc.; Argon Medical Devices, Inc.; Boston Scientific Corporation; Edwards Lifesciences Corporation; Johnson & Johnson Services, Inc. (Cerenovus); LeMaitre Vascular, Inc.; Medtronic plc; MicroVention, Inc. (a subsidiary of Terumo Corporation); Penumbra, Inc.; Phenox GmbH; Stryker Corporation; Terumo Corporation; and Vesalio, LLC.

Polaris Market Research has segmented the neurothrombectomy devices market report on the basis of product, end use, and region:

By Product Outlook (Revenue - USD Million, 2020-2034)

Clot Retrievers

Aspiration/Suction Devices

Vascular Snares

By End Use Outlook (Revenue - USD Million, 2020-2034)

Hospitals

Emergency Clinics

Ambulatory Surgical Centers

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Neurothrombectomy Devices Market Insights

• 4.1. Neurothrombectomy Devices Market - Market Snapshot
• 4.2. Neurothrombectomy Devices Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Rising Incidence of Ischemic Strokes
    • 4.2.1.2. Advancements in Mechanical Thrombectomy Procedures
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. High procedural costs
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Neurothrombectomy Devices Market Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Neurothrombectomy Devices Market, by Product

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
• 5.3. Clot Retrievers
  • 5.3.1. Global Neurothrombectomy Devices Market, by Clot Retrievers, by Region, 2020-2034 (USD Million)
• 5.4. Aspiration/Suction Devices
  • 5.4.1. Global Neurothrombectomy Devices Market, by Aspiration/Suction Devices, by Region, 2020-2034 (USD Million)
• 5.5. Vascular Snares
  • 5.5.1. Global Neurothrombectomy Devices Market, by Vascular Snares, by Region, 2020-2034 (USD Million)

6. Global Neurothrombectomy Devices Market, by End-Use

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• 6.3. Hospitals
  • 6.3.1. Global Neurothrombectomy Devices Market, by Hospitals, by Region, 2020-2034 (USD Million)
• 6.4. Emergency Clinics
  • 6.4.1. Global Neurothrombectomy Devices Market, by Emergency Clinics, by Region, 2020-2034 (USD Million)
• 6.5. Ambulatory Surgical Centers
  • 6.5.1. Global Neurothrombectomy Devices Market, by Ambulatory Surgical Centers, by Region, 2020-2034 (USD Million)

7. Global Neurothrombectomy Devices Market, by Geography

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Neurothrombectomy Devices Market Assessment, By Geography, 2020-2034 (USD Million)
• 7.3. Neurothrombectomy Devices Market - North America
  • 7.3.1. North America: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
  • 7.3.2. North America: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.3.3. Neurothrombectomy Devices Market - U.S.
    • 7.3.3.1. U.S.: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.3.3.2. U.S.: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.3.4. Neurothrombectomy Devices Market - Canada
    • 7.3.4.1. Canada: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.3.4.2. Canada: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• 7.4. Neurothrombectomy Devices Market - Europe
  • 7.4.1. Europe: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
  • 7.4.2. Europe: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.4.3. Neurothrombectomy Devices Market - UK
    • 7.4.3.1. UK: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.4.3.2. UK: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.4.4. Neurothrombectomy Devices Market - France
    • 7.4.4.1. France: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.4.4.2. France: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.4.5. Neurothrombectomy Devices Market - Germany
    • 7.4.5.1. Germany: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.4.5.2. Germany: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.4.6. Neurothrombectomy Devices Market - Italy
    • 7.4.6.1. Italy: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.4.6.2. Italy: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.4.7. Neurothrombectomy Devices Market - Spain
    • 7.4.7.1. Spain: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.4.7.2. Spain: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.4.8. Neurothrombectomy Devices Market - Netherlands
    • 7.4.8.1. Netherlands: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.4.8.2. Netherlands: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.4.9. Neurothrombectomy Devices Market - Russia
    • 7.4.9.1. Russia: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.4.9.2. Russia: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.4.10. Neurothrombectomy Devices Market - Rest of Europe
    • 7.4.10.1. Rest of Europe: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.4.10.2. Rest of Europe: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• 7.5. Neurothrombectomy Devices Market - Asia Pacific
  • 7.5.1. Asia Pacific: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
  • 7.5.2. Asia Pacific: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.5.3. Neurothrombectomy Devices Market - China
    • 7.5.3.1. China: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.5.3.2. China: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.5.4. Neurothrombectomy Devices Market - India
    • 7.5.4.1. India: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.5.4.2. India: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.5.5. Neurothrombectomy Devices Market - Malaysia
    • 7.5.5.1. Malaysia: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.5.5.2. Malaysia: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.5.6. Neurothrombectomy Devices Market - Japan
    • 7.5.6.1. Japan: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.5.6.2. Japan: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.5.7. Neurothrombectomy Devices Market - Indonesia
    • 7.5.7.1. Indonesia: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.5.7.2. Indonesia: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.5.8. Neurothrombectomy Devices Market - South Korea
    • 7.5.8.1. South Korea: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.5.8.2. South Korea: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.5.9. Neurothrombectomy Devices Market - Australia
    • 7.5.9.1. Australia: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.5.9.2. Australia: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.5.10. Neurothrombectomy Devices Market - Rest of Asia Pacific
    • 7.5.10.1. Rest of Asia Pacific: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.5.10.2. Rest of Asia Pacific: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• 7.6. Neurothrombectomy Devices Market - Middle East & Africa
  • 7.6.1. Middle East & Africa: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
  • 7.6.2. Middle East & Africa: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.6.3. Neurothrombectomy Devices Market - Saudi Arabia
    • 7.6.3.1. Saudi Arabia: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.6.3.2. Saudi Arabia: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.6.4. Neurothrombectomy Devices Market - UAE
    • 7.6.4.1. UAE: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.6.4.2. UAE: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.6.5. Neurothrombectomy Devices Market - Israel
    • 7.6.5.1. Israel: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.6.5.2. Israel: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.6.6. Neurothrombectomy Devices Market - South Africa
    • 7.6.6.1. South Africa: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.6.6.2. South Africa: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.6.7. Neurothrombectomy Devices Market - Rest of Middle East & Africa
    • 7.6.7.1. Rest of Middle East & Africa: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.6.7.2. Rest of Middle East & Africa: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
• 7.7. Neurothrombectomy Devices Market - Latin America
  • 7.7.1. Latin America: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
  • 7.7.2. Latin America: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.7.3. Neurothrombectomy Devices Market - Mexico
    • 7.7.3.1. Mexico: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.7.3.2. Mexico: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.7.4. Neurothrombectomy Devices Market - Brazil
    • 7.7.4.1. Brazil: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.7.4.2. Brazil: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.7.5. Neurothrombectomy Devices Market - Argentina
    • 7.7.5.1. Argentina: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.7.5.2. Argentina: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)
  • 7.7.6. Neurothrombectomy Devices Market - Rest of Latin America
    • 7.7.6.1. Rest of Latin America: Neurothrombectomy Devices Market, by Product, 2020-2034 (USD Million)
    • 7.7.6.2. Rest of Latin America: Neurothrombectomy Devices Market, by End-Use, 2020-2034 (USD Million)

8. Competitive Landscape

• 8.1. Expansion and Acquisition Analysis
  • 8.1.1. Expansion
  • 8.1.2. Acquisitions
• 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

• 9.1. Abbott Laboratories
  • 9.1.1. Company Overview
  • 9.1.2. Financial Performance
  • 9.1.3. Product Benchmarking
  • 9.1.4. Recent Development
• 9.2. Acandis GmbH
  • 9.2.1. Company Overview
  • 9.2.2. Financial Performance
  • 9.2.3. Product Benchmarking
  • 9.2.4. Recent Development
• 9.3. AngioDynamics, Inc.
  • 9.3.1. Company Overview
  • 9.3.2. Financial Performance
  • 9.3.3. Product Benchmarking
  • 9.3.4. Recent Development
• 9.4. Argon Medical Devices, Inc.
  • 9.4.1. Company Overview
  • 9.4.2. Financial Performance
  • 9.4.3. Product Benchmarking
  • 9.4.4. Recent Development
• 9.5. Boston Scientific Corporation
  • 9.5.1. Company Overview
  • 9.5.2. Financial Performance
  • 9.5.3. Product Benchmarking
  • 9.5.4. Recent Development
• 9.6. Edwards Lifesciences Corporation
  • 9.6.1. Company Overview
  • 9.6.2. Financial Performance
  • 9.6.3. Product Benchmarking
  • 9.6.4. Recent Development
• 9.7. Johnson & Johnson Services, Inc. (Cerenovus)
  • 9.7.1. Company Overview
  • 9.7.2. Financial Performance
  • 9.7.3. Product Benchmarking
  • 9.7.4. Recent Development
• 9.8. LeMaitre Vascular, Inc.
  • 9.8.1. Company Overview
  • 9.8.2. Financial Performance
  • 9.8.3. Product Benchmarking
  • 9.8.4. Recent Development
• 9.9. Medtronic plc
  • 9.9.1. Company Overview
  • 9.9.2. Financial Performance
  • 9.9.3. Product Benchmarking
  • 9.9.4. Recent Development
• 9.10. MicroVention, Inc. (a subsidiary of Terumo Corporation)
  • 9.10.1. Company Overview
  • 9.10.2. Financial Performance
  • 9.10.3. Product Benchmarking
  • 9.10.4. Recent Development